Breaking News Instant updates and real-time market news.

IQV

Iqvia

$99.13

-2.99 (-2.93%)

09:07
05/17/18
05/17
09:07
05/17/18
09:07

Iqvia data issues only 'minor fundamental risk,' sayst William Blair

William Blair analyst John Kreger views the FDA's "stern rebuke" of Iqvia's data quality as a "moderate public relations problem for the company." From a fundamental standpoint, the analyst does not see the "episode turning into a demand or cost problem." Iqvia's data streams are often adjusted after the fact as more information becomes available, Kreger tells investors in a research note. As such, he thinks the vast majority of the company's biopharmaceutical clients would not be surprised or alarmed by such changes in the data set. The analyst keeps an Outperform rating on the shares, viewing yesterday's developments as only a "minor fundamental risk."

  • 16

    May

IQV Iqvia
$99.13

-2.99 (-2.93%)

05/16/18
EVER
05/16/18
NO CHANGE
Target $113
EVER
Outperform
FDA report on Iqvia data quality a 'non-issue,' says Evercore ISI
After the FDA reported certain issues with Iqvia's sales data regarding opioid drug products, Evercore ISI analyst Ross Muken called the news a "non-issue," stating that it has nothing to do with the company's clinical trial business and is "purely a minor error in the sales data." He believes the stocks' pullback on the news is an overreaction and would be a buyer of any continued weakness. Muken has an Outperform rating and $113 price target on Iqvia shares, which are down about 4% to $97.66 in early afternoon trading.
05/16/18
BARD
05/16/18
NO CHANGE
Target $109
BARD
Neutral
Iqvia quality issues 'more than just a small overhang,' says Baird
Baird analyst Eric Coldwell says that while his initial thought upon hearing of the data quality issues was buy the weakness in Iqvia shares, he now feels the news represents "more than just a small overhang." The FDA data quality issue is a "new risk and all the potential ramifications will take some time to digest," Coldwell tells investors in an intraday research note. Iqvia is well off the day's lows but remains down 4.6% to $97.43 in afternoon trading. Coldwell has a Neutral rating on the shares with a $109 price target. He points out that FDA Commissioner Gottlieb is calling for Iqvia to immediately retain an auditor to review the controlled substance data and separately retain a third party to do an independent audit of data and process quality for all of its products used by the agency.
05/16/18
STFL
05/16/18
NO CHANGE
Target $128
STFL
Buy
Cost, scope of FDA requested audit key questions for Iqvia, says Stifel
After the FDA reported its scientists found inaccurate data items provided to the agency by an Iqvia database and requested the company hire an independent third party auditor to review the data quality and control procedures of all Iqvia products used by the agency, Stifel analyst Shlomo Rosenbaum said it is tough to gauge the potential magnitude and impact of the news. He sees the cost of an audit and the issue of whether the scope of the audit could be significantly expanded as the key questions. While stating that "the optics of the situation are not ideal," Rosenbaum is maintaining a Buy rating and $128 price target on Iqvia shares.
05/17/18
MZHO
05/17/18
NO CHANGE
Target $97
MZHO
Neutral
Iqvia data issues 'likely just a hiccup,' says Mizuho
Mizuho analyst Ann Hynes believes the data issues brought up yesterday by the FDA are "likely just a hiccup" for Iqvia. The analyst feels comfortable that the issue does not have ramifications on a significant portion of Iqvia's business, and that the issue has been resolved. She reiterates a Neutral rating on the shares with a $97 price target.

TODAY'S FREE FLY STORIES

03:35
08/21/18
08/21
03:35
08/21/18
03:35
General news
FX Action: USD-CAD has descended to a 12-day low »

FX Action: USD-CAD has…

02:35
08/21/18
08/21
02:35
08/21/18
02:35
General news
FX Update: The Dollar has come under broad pressure »

FX Update: The Dollar has…

01:50
08/21/18
08/21
01:50
08/21/18
01:50
General news
Asian Markep Wrap: »

Asian Markep Wrap:…

BOLD

Audentes Therapeutics

$33.74

0.7 (2.12%)

20:43
08/20/18
08/20
20:43
08/20/18
20:43
Initiation
Audentes Therapeutics initiated at Citi »

Audentes Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

VNOM

Viper Energy

$38.06

-0.29 (-0.76%)

20:42
08/20/18
08/20
20:42
08/20/18
20:42
Upgrade
Viper Energy rating change at Citi »

Viper Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCPH

scPharmaceuticals

$4.94

-0.43 (-8.01%)

20:25
08/20/18
08/20
20:25
08/20/18
20:25
Recommendations
scPharmaceuticals analyst commentary at BMO Capital »

scPharmaceuticals'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

MDT

Medtronic

$90.06

-0.54 (-0.60%)

, TJX

TJX

$101.68

1.33 (1.33%)

20:25
08/20/18
08/20
20:25
08/20/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MDT

Medtronic

$90.06

-0.54 (-0.60%)

TJX

TJX

$101.68

1.33 (1.33%)

SJM

J.M. Smucker

$115.92

1.35 (1.18%)

KSS

Kohl's

$78.86

2.43 (3.18%)

COTY

Coty

$12.41

0.19 (1.55%)

TOL

Toll Brothers

$34.72

0.33 (0.96%)

PINC

Premier

$38.35

-0.03 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 23

    Aug

  • 05

    Sep

  • 12

    Sep

  • 14

    Sep

BHP

BHP Billiton

$48.30

0.38 (0.79%)

19:33
08/20/18
08/20
19:33
08/20/18
19:33
Hot Stocks
Breaking Hot Stocks news story on BHP Billiton »

BHP CEO says looking to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGE

Tallgrass Energy

$26.23

0.63 (2.46%)

19:23
08/20/18
08/20
19:23
08/20/18
19:23
Recommendations
Tallgrass Energy analyst commentary at MUFG »

Tallgrass Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRY

Tilray

$35.91

5.2 (16.93%)

19:18
08/20/18
08/20
19:18
08/20/18
19:18
Hot Stocks
Tilray Canada reaches pact with OCRC to supply cannabis brands, products »

Tilray Canada announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

LFL

LATAM Airlines

$0.00

(0.00%)

19:10
08/20/18
08/20
19:10
08/20/18
19:10
Earnings
LATAM Airlines reports Q2 operating income $6.5M vs. $48.2M last year »

Reports Q2 revenue $2.36B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNOV

MediciNova

$8.99

-0.11 (-1.21%)

19:08
08/20/18
08/20
19:08
08/20/18
19:08
Hot Stocks
MediciNova says NIH awards research griant to UCLA for MN-166 trial »

MediciNova announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTZ

Hertz

$21.05

0.155 (0.74%)

, FN

Fabrinet

$44.00

0.365 (0.84%)

18:45
08/20/18
08/20
18:45
08/20/18
18:45
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

HTZ

Hertz

$21.05

0.155 (0.74%)

FN

Fabrinet

$44.00

0.365 (0.84%)

WDAY

Workday

$143.17

0.52 (0.36%)

SITO

Sito Mobile

$1.99

0.05 (2.58%)

NDSN

Nordson

$134.67

-0.12 (-0.09%)

APPN

Appian

$36.23

(0.00%)

CREE

Cree

$46.42

0.99 (2.18%)

MELI

MercadoLibre

$319.70

-4.3 (-1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 20

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 04

    Sep

  • 04

    Sep

  • 06

    Sep

  • 07

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

  • 21

    Aug

IBKR

Interactive Brokers

$61.99

0.76 (1.24%)

18:43
08/20/18
08/20
18:43
08/20/18
18:43
Hot Stocks
FINRA fines Interactive Brokers $5.5M for regulation SHO violations »

FINRA announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$106.87

-0.71 (-0.66%)

18:29
08/20/18
08/20
18:29
08/20/18
18:29
Hot Stocks
LinkedIn to let economics researchers mine its data »

Microsoft's LinkedIn…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Sep

GSB

GlobalSCAPE

$3.46

(0.00%)

18:27
08/20/18
08/20
18:27
08/20/18
18:27
Hot Stocks
GlobalSCAPE to launch $15M modified Dutch auction tender offer »

GlobalSCAPE announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

BHP

BHP Billiton

$48.30

0.38 (0.79%)

18:24
08/20/18
08/20
18:24
08/20/18
18:24
Earnings
BHP reports FY18 underlying profit $9.6B, consensus $9.2B according to Bloomberg »

BHP reports copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$225.37

2.76 (1.24%)

18:19
08/20/18
08/20
18:19
08/20/18
18:19
Earnings
Lennox cuts FY18 adjusted EPS view to $8.90-$9.30 from $9.95-$10.35 »

FY18 consensus $10.25.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDI

Gardner Denver

$28.29

0.36 (1.29%)

18:10
08/20/18
08/20
18:10
08/20/18
18:10
Initiation
Gardner Denver initiated at Morgan Stanley »

Gardner Denver initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$204.57

-0.24 (-0.12%)

18:09
08/20/18
08/20
18:09
08/20/18
18:09
Initiation
3M initiated at Morgan Stanley »

3M initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETN

Eaton

$81.33

0.35 (0.43%)

18:05
08/20/18
08/20
18:05
08/20/18
18:05
Initiation
Eaton initiated at Morgan Stanley »

Eaton initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLS

Flowserve

$51.51

0.16 (0.31%)

18:01
08/20/18
08/20
18:01
08/20/18
18:01
Initiation
Flowserve initiated at Morgan Stanley »

Flowserve initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITW

Illinois Tool Works

$138.37

-1.05 (-0.75%)

17:59
08/20/18
08/20
17:59
08/20/18
17:59
Initiation
Illinois Tool Works initiated at Morgan Stanley »

Illinois Tool Works…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFX

Colfax

$33.28

0.62 (1.90%)

17:56
08/20/18
08/20
17:56
08/20/18
17:56
Initiation
Colfax initiated at Morgan Stanley »

Colfax initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALLE

Allegion

$86.97

0.26 (0.30%)

17:54
08/20/18
08/20
17:54
08/20/18
17:54
Initiation
Allegion initiated at Morgan Stanley »

Allegion initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.